Related Experiment Video
Updated: Apr 12, 2026

06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.8K
Procedural volume and outcomes of Impella support in cardiogenic shock
Yuji Nishimoto1,2, Atsushi Kikuchi3, Yukihito Sato4
1Department of Cardiology, Toyonaka Municipal Hospital, 4-14-1 Shibahara, Toyonaka, 560-8565, Osaka, Japan. yuji.nishimoto@gmail.com.
Critical Care (London, England)
|April 10, 2026
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
681
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
681
Heart Failure VI: Adjunct Therapies
599
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
599

